.After antibody-drug conjugate (ADC) professional Seagen was offered to Pfizer last year for a monst...
.On the heels of a phase 3 gain that fell short to wow entrepreneurs, Ironwood Pharmaceuticals is ba...
.Don't cease Monte Rosa Therapies now. The Boston-based biotech is having a ball after authorizing a...
.Accept to this week's Chutes & Ladders, our summary of considerable management hirings, shooting...
.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer called t...
.AbbVie has actually come back to the resource of its own antipsychotic giant Vraylar searching for ...
.GenSight Biologics is full weeks off of running out of loan. Once again. The biotech simply has eno...
.Monopar Therapeutics is recovering a drug from the scrap heap of AstraZeneca's uncommon ailment pip...
.With new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of professionals e...
.After forming a genetics therapy collaboration with Dyno Therapies in 2020, Roche is back for even ...